Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-032020
Filing Date
2022-02-09
Accepted
2022-02-09 09:31:01
Documents
1
Group Members
FARHAD NANJIMFN PARTNERS GP, LLCMFN PARTNERS MANAGEMENT, LLCMFN PARTNERS MANAGEMENT, LPMICHAEL F. DEMICHELE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d286138dsc13ga.htm SC 13G/A 89762
  Complete submission text file 0001193125-22-032020.txt   91370
Mailing Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116 617-443-2040
MFN Partners, LP (Filed by) CIK: 0001732960 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Subject) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90979 | Film No.: 22604522
SIC: 2834 Pharmaceutical Preparations